ÂÜÀòÂÒÂ×

Kelly Doolin, PhD has a diverse work experience. In 2007, they worked as a Net Guide at the Reading Public Library. From 2010 to 2011, they were a Laboratory Intern at Emmanuel College and Beth Israel Deaconess Medical Center. In 2012, they worked as a Research Assistant at Brigham and Women's Hospital. From 2013 to 2018, they were a Postdoctoral Research Fellow and a Doctoral Researcher at Trinity College Dublin, where they also served as Treasurer of the Neuroscience Society. In 2019, they were a Project Manager at ICON plc. From 2020 to 2022, they were a Clinical Trial Liaison at Theravance Biopharma US, Inc. and is currently a Clinical Scientific Expert at GH Research.

Kelly Doolin, PhD, obtained their Doctor of Philosophy (PhD) in Psychiatry from Trinity College Dublin in 2017. Prior to that, they obtained their Master of Science (M.Sc.) in Neuroscience from Trinity College Dublin in 2012. Kelly also obtained their Bachelor of Sciences in Biology and Neuroscience from Emmanuel College (Boston) in 2011. Kelly obtained their High School degree from Reading Memorial High School in 2008. In 2021, they obtained a Professional Certificate in Clinical Pharmacology, Drug Development and Regulation from the Tufts Center for the Study of Drug Development. Kelly also holds an ICH GCP certification from TransCelerate BioPharma Inc.